Development of HepG2-severe combined immunodeficiency mouse model for dengue virus infection

CHEN Yan-lei, WANG Juan, GAO Na, FAN Dong-Ying,WANG Yi-Song, AN Jing

Journal of Microbes and Infections ›› 2013, Vol. 8 ›› Issue (1) : 16-20.

PDF(13935 KB)
Welcome to visit Journal of Microbes and Infections,
PDF(13935 KB)
Journal of Microbes and Infections ›› 2013, Vol. 8 ›› Issue (1) : 16-20.
Article

Development of HepG2-severe combined immunodeficiency mouse model for dengue virus infection

  • CHEN Yan-lei, WANG Juan, GAO Na, FAN Dong-Ying,WANG Yi-Song, AN Jing
Author information +
History +

Abstract

The purpose of the current study is to develop a mouse model for exploration of the pathogenesis of dengue virus (DENV) infection. HepG2 cells were transplanted to severe combined immunodeficiency (SCID) mice intraperitoneally to develop a HepG2-SCID mouse chimera model. To confirm the successful transplantation , the concentration of human albumin (hALB) in the serum was determined by sandwich enzyme-linked immunosorbent assay. Following challenge with intraperitoneal injection of DENV2, HepG2- SCID mice were evaluated by detection of virus distribution and histological changes in major organs. HepG2 cells engrafted into SCID mouse could support the replication of DENV2. HepG2-SCID mouse showed viremia and severe organ injuries. The data suggest that DENV2-infected HepG2-SCID chimera model is developed successfully , which would provide a useful tool for studying pathogenesis of DENV infection.

Key words

Dengue virus / Animal model / HepG2 cell

Cite this article

Download Citations
CHEN Yan-lei, WANG Juan, GAO Na, FAN Dong-Ying,WANG Yi-Song, AN Jing. Development of HepG2-severe combined immunodeficiency mouse model for dengue virus infection[J]. Journal of Microbes and Infections. 2013, 8(1): 16-20
PDF(13935 KB)

Accesses

Citation

Detail

Sections
Recommended

/